Application 207499
- Type
- ANDA
- Sponsor
- NEXUS PHARMS
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | SODIUM NITROPRUSSIDE | SODIUM NITROPRUSSIDE | INJECTABLE;INJECTION | 25MG/ML | No | No |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 14789-012 | sodium nitroprusside | sodium nitroprusside | Nexus Pharmaceuticals Inc | ANDA | Current |
| 14789-012 | Sodium Nitroprusside | Sodium Nitroprusside | Nexus Pharmaceuticals Inc | ANDA | Current |
| 14789-012 | Sodium Nitroprusside | Sodium Nitroprusside | Nexus Pharmaceuticals Inc | ANDA | Current |
| 14789-012 | sodium nitroprusside | sodium nitroprusside | Nexus Pharmaceuticals Inc | ANDA | Current |